INSTIL BIO, INC. : Other Events, Financial Statements and Exhibits (form 8-K)

Item 8.01 Other Events.

On January 9, 2023, Instil Bio, Inc. (the "Company") issued a press release entitled "Instil Bio Announces Resumption of Clinical Trial of CoStAR-TIL Candidate ITIL-306 in Lung, Ovarian, and Renal Cancer." The full text of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01 Financial Statements and Exhibits.

(d)   Exhibits



 Exhibit No.       Description
     99.1            Press release, dated January 9, 2023.
     104           The cover page of this report has been formatted in Inline XBRL.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses